These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32436657)

  • 1. Incidence and survival of rare cancers in the US and Europe.
    Botta L; Gatta G; Trama A; Bernasconi A; Sharon E; Capocaccia R; Mariotto AB;
    Cancer Med; 2020 Aug; 9(15):5632-5642. PubMed ID: 32436657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
    Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A;
    Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of rare cancers and inequalities in oncologic outcomes.
    Gatta G; Trama A; Capocaccia R;
    Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare cancers are not so rare: the rare cancer burden in Europe.
    Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R;
    Eur J Cancer; 2011 Nov; 47(17):2493-511. PubMed ID: 22033323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.
    Mallone S; De Angelis R; van der Zwan JM; Trama A; Siesling S; Gatta G; Capocaccia R;
    Cancer Epidemiol; 2013 Dec; 37(6):850-6. PubMed ID: 24050903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Survival of Patients With Conjunctival Melanoma in Europe.
    Virgili G; Parravano M; Gatta G; Capocaccia R; Mazzini C; Mallone S; Botta L;
    JAMA Ophthalmol; 2020 Jun; 138(6):601-608. PubMed ID: 32215588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based comparison of European and North American sinonasal cancer survival.
    Unsal AA; Kılıç S; Dubal PM; Baredes S; Eloy JA;
    Auris Nasus Larynx; 2018 Aug; 45(4):815-824. PubMed ID: 29056464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of rare cancers in the United States.
    DeSantis CE; Kramer JL; Jemal A
    CA Cancer J Clin; 2017 Jul; 67(4):261-272. PubMed ID: 28542893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare cancers of the head and neck area in Europe.
    Van Dijk BA; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L;
    Eur J Cancer; 2012 Apr; 48(6):783-96. PubMed ID: 22051735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology.
    Gatta G; Ciccolallo L; Capocaccia R; Coleman MP; Hakulinen T; Møller H; Berrino F;
    Eur J Cancer; 2003 Oct; 39(15):2214-22. PubMed ID: 14522381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
    Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
    Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood cancer survival in Europe and the United States.
    Gatta G; Capocaccia R; Coleman MP; Ries LA; Berrino F
    Cancer; 2002 Oct; 95(8):1767-72. PubMed ID: 12365026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of cancer incidence and mortality in Europe in 1995.
    Bray F; Sankila R; Ferlay J; Parkin DM
    Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of rare cancers in Europe.
    Gatta G; Capocaccia R; Trama A; Martínez-García C;
    Adv Exp Med Biol; 2010; 686():285-303. PubMed ID: 20824452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descriptive epidemiological study of rare, less common and common cancers in Western Australia.
    Bilkey GA; Trevithick RW; Coles EP; Girschik J; Nowak KJ
    BMC Cancer; 2021 Jul; 21(1):779. PubMed ID: 34233636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a comparison of survival in American and European cancer patients.
    Gatta G; Capocaccia R; Coleman MP; Gloeckler Ries LA; Hakulinen T; Micheli A; Sant M; Verdecchia A; Berrino F
    Cancer; 2000 Aug; 89(4):893-900. PubMed ID: 10951355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.
    Sirri E; Kieschke J; Vohmann C; Katalinic A; Nennecke A; Ressing M; Eberle A; Holleczek B; Jansen L; Brenner H;
    Int J Cancer; 2020 Sep; 147(6):1548-1558. PubMed ID: 32072636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood cancer survival trends in Europe: a EUROCARE Working Group study.
    Gatta G; Capocaccia R; Stiller C; Kaatsch P; Berrino F; Terenziani M;
    J Clin Oncol; 2005 Jun; 23(16):3742-51. PubMed ID: 15923571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.